Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters
2022 · Vaccine · 6 citations
https://doi.org/10.1016/j.vaccine.2022.07.005